When to increase your Mounjaro dose for weight loss

You've just finished your first pen and you're wondering: is it working?

This is exactly where most people find themselves after the first four weeks on 2.5 mg. The dose feels underwhelming. The scale has barely moved. And the internet is full of people claiming they lost a stone in a month. It's worth being honest about what the starter dose is actually doing: the first pen's job is adjustment. The 2.5 mg step is not a therapeutic weight-loss dose, it is there to help your gut, appetite signalling and blood-sugar response adapt to the medicine before the dose climbs. Significant weight loss typically begins once you're established on 5 mg or above.

A question our prescribers hear most weeks is whether it's safe to skip a step if tolerability is fine. The short answer: only your prescriber can make that call. The NHS tirzepatide medicines page describes the standard four-weekly titration schedule, and deviating from it requires a clinical judgment about your individual risk profile. At nume, your consultation is reviewed by a GPhC-registered Independent Prescriber, a real clinician reads your answers before any dose is confirmed or changed. Tolerating 2.5 mg well is a positive sign, but it is one input among several.

If four weeks have passed, your side effects were manageable, and your prescriber has agreed, moving to 5 mg is the expected next step. Understanding which Mounjaro dose is right for weight loss helps frame what to expect at each level.

The signals that suggest a dose increase is appropriate

There is no single trigger. Prescribers typically look at a combination of factors before agreeing to a step up. Tolerability is the first gate: persistent nausea, repeated vomiting, or severe gastrointestinal disruption are reasons to stay at the current dose longer, or even pause. If those symptoms have settled (usually within the first ten to fourteen days of a new dose) the body has likely adapted enough to consider progressing.

Weight response is the second factor. Some people lose meaningful weight at lower doses and their prescriber may decide that increasing further is not necessary at that point. Others plateau early: weight loss that was steady slows or stops for three to four weeks at the same dose. A plateau can mean the current dose is no longer producing sufficient appetite suppression for your physiology, which is one of the clearer reasons to discuss going up. The question of whether increasing Mounjaro dose improves weight loss is covered in detail elsewhere, but the short version is: for most people, higher doses do produce greater average reduction, with the evidence from SURMOUNT-1 showing around 20–21% average body-weight reduction at 15 mg over 72 weeks, compared to more modest losses at lower maintenance doses.

Time at dose matters too. Four weeks is the minimum interval between increases; rushing that window is not a clinical option. And if you are still within the first fortnight at a new dose, any side effects you are experiencing have not yet had a fair chance to settle. Stay the course for the full period before drawing conclusions. You can explore more on tirzepatide dose timing if you want a broader view of the evidence behind these intervals.

When staying at your current dose is the right decision

Not every review results in a step up, and that is not a failure. There are situations where holding the current dose is clinically sensible. Ongoing nausea or diarrhoea that hasn't settled by week two suggests your gut needs more time. A recent illness that caused significant dehydration can distort how you feel on the medicine. Travel, disrupted eating patterns, or a course of another medicine can all affect how tolerable a dose feels in a given month.

There is also a ceiling. 15 mg is the maximum licensed dose, and some people reach their personal sweet spot below it, good tolerability and steady weight loss at 10 mg, for instance, is a perfectly valid place to stay. The 15 mg maintenance dose information explains what to expect at the top of the schedule, but it is not a target every person needs to reach.

NICE's appraisal of tirzepatide notes that if weight loss is less than 5% after six months at the highest tolerated dose, continuing should be formally reviewed. That threshold gives both patient and prescriber a concrete benchmark. Cost is also real: how Mounjaro is priced in the UK changes at each dose level, and it's reasonable to factor that into a conversation with your prescriber, honestly, not as a reason to rush up or avoid going up.

How to raise a dose-change question with your prescriber

Be specific. Arrive at your review knowing how your side effects felt across the four weeks, not just at the worst or best point. A rough log (even a note on your phone) helps enormously. Record your weight at the same time each week (morning, before eating), because day-to-day fluctuation can be misleading. If your loss has clearly stalled for three or more weeks and your tolerability has been good, that is a strong and clear case for a step up.

What you should not do is adjust the dose yourself, borrow someone else's pen, or stay silent if something feels wrong. If you are unsure whether your progress is on track, the practical strategies for improving weight loss on Mounjaro page covers the lifestyle factors that work alongside dose. And if you have broader questions about how the treatment fits your situation, our FAQs address the most common ones our prescribers field. When you're ready to speak to someone directly, starting a free consultation puts your question in front of a GPhC-registered prescriber the same day.